Kristjansdottir, Hallgerdur Lind
Mellström, Dan
Johansson, Peter
Karlsson, Magnus
Vandenput, Liesbeth
Lorentzon, Mattias
Herlitz, Hans
Ohlsson, Claes
Lerner, Ulf H.
Lewerin, Catharina
Funding for this research was provided by:
Göteborgs Läkaresällskap (880451)
Sahlgrenska Universitetssjukhuset (890891)
Swedish state, ALF agreement (872941)
University of Gothenburg
Article History
Received: 28 December 2021
Accepted: 15 June 2022
First Online: 23 June 2022
Declarations
:
: Hallgerdur Lind Kristjansdottir, Dan Mellström, Peter Johansson, Magnus Karlsson, Liesbeth Vandenput, Hans Herlitz, Ulf H. Lerner, and Catharina Lewerin have no disclosures. Mattias Lorentzon has received lecture or consulting fees from Amgen, Lilly, Meda, UCB Pharma, Renapharma, Radius Health, and Consilient Health, all outside the submitted work. Claes Ohlsson has two patent applications within the field of probiotics and osteoporosis.